The issue of vaginal dryness in genitourinary syndrome of menopause (GSM) and its pervasive impact on women's quality of life is often overlooked. Extensive surveys conducted worldwide reveal limited understanding of vaginal dryness among public and health-care providers. Physician knowledge on menopause medicine varies globally, highlighting the need for standardized training. Effective communication between physicians and patients plays a crucial role in diagnosing and treating GSM symptoms. There are multiple treatment options to improve vaginal lubrication, including hormonal and non-hormonal therapies, along with lifestyle modifications. Tailoring treatments to individual patient preferences is crucial for compliance. Overall, GSM is multifaceted, from the prevalence of vaginal dryness to the nuances of treatment preferences. The urgency of widespread education and awareness of this matter must be underscored to meet the aim of enhancing the well-being and quality of life for women.
Keyphrases
- healthcare
- polycystic ovary syndrome
- primary care
- end stage renal disease
- emergency department
- newly diagnosed
- physical activity
- chronic kidney disease
- ejection fraction
- metabolic syndrome
- risk factors
- insulin resistance
- type diabetes
- pregnancy outcomes
- decision making
- cross sectional
- cervical cancer screening
- depressive symptoms
- adipose tissue
- skeletal muscle
- adverse drug
- urinary incontinence